Revenue and profit forecasts fail to justify the hype baked into Moderna’s share price, according to Citi’s analysts.
Source: [MarketWatch](https://www.marketwatch.com/story/citi-tells-investors-its-time-to-sell-moderna-after-600-plus-stock-gains-84cb9b62?mod=mw_rss_topstories)